Drug General Information
Drug ID	D0ER5C
Former ID	DNC007089
Drug Name	6-hydroxy-2,9-dimethyl-9H-beta-carbolin-2-ium
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528415]
Structure		Download 2D MOL 3D MOL
Formula	C13H13N2O+
Canonical SMILES	CN1C2=C(C=C(C=C2)O)C3=C1C=[N+](C=C3)C
InChI	1S/C13H12N2O/c1-14-6-5-10-11-7-9(16)3-4-12(11)15(2)13(10)8-14/h3-8H,1-2H3/p+1
InChIKey	OEJPDCAOADNKRJ-UHFFFAOYSA-O
PubChem Compound ID	44419701
Target and Pathway
Target(s)	Acetylcholinesterase	Target Info	Inhibitor	[528415]
KEGG Pathway	Glycerophospholipid metabolism
	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer Pathway
References
Ref 528415	Bioorg Med Chem Lett. 2006 Nov 15;16(22):5840-3. Epub 2006 Sep 1.6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
Ref 528415	Bioorg Med Chem Lett. 2006 Nov 15;16(22):5840-3. Epub 2006 Sep 1.6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.